About
Treatments for fibrotic diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
684
By Phase
PHASE2: 6PHASE1: 1EARLY_PHASE1: 1
By Status
COMPLETED: 5TERMINATED: 2RECRUITING: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06097260Lead Sponsor
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
PHASE2Terminated
320 participants
Started: Nov 16, 2023 · Completed: Apr 4, 2025
NCT06270706Lead Sponsor
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
77 participants
Started: Aug 30, 2023 · Completed: Dec 31, 2025
NCT05621252Lead Sponsor
Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)
PHASE2Completed
10 participants
Started: Jul 13, 2022 · Completed: Jan 8, 2024
NCT04565249Lead Sponsor
Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
PHASE2Terminated
6 participants
Started: Oct 22, 2020 · Completed: Aug 2, 2021
NCT04480840Lead Sponsor
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
PHASE2Completed
121 participants
Started: Jul 27, 2020 · Completed: Mar 18, 2024
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...